Lucia Ortiz
Family · Bakersfield, CANPI 1235903865
Payments from drug & device makers
Across 209 payments — averaging $27.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$708
- Amgen$666
- Novo Nordisk$647
- Lilly USA, LLC$501
- Boehringer Ingelheim$404
- AstraZeneca$319
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,747100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 16 | $708 |
| Amgen | 29 | $666 |
| Novo Nordisk | 25 | $647 |
| Lilly USA, LLC | 14 | $501 |
| Boehringer Ingelheim | 10 | $404 |
| AstraZeneca | 11 | $319 |
| Bayer | 4 | $269 |
| AbbVie | 13 | $254 |
| Phathom Pharmaceuticals, Inc. | 12 | $253 |
| Medtronic | 2 | $166 |
| GSK | 12 | $163 |
| Ardelyx, Inc. | 9 | $161 |
| Aimmune Therapeutics, Inc. | 12 | $157 |
| Abiomed | 2 | $149 |
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Astellas Pharma US Inc | 5 | $106 |
| Daiichi Sankyo Inc. | 1 | $104 |
| Glaukos Corporation | 1 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $69 |
| Merck | 3 | $66 |
| Revance Therapeutics, Inc. | 1 | $59 |
| Hologic Sales And Service, LLC | 2 | $52 |
| Vertex | 2 | $44 |
| Organogenesis Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Exact Sciences | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Radius Health, Inc. | 1 | $27 |
| Organon | 2 | $21 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,747 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $30,171 |
| FarxigaDapagliflozin Propanediol | 42 | $27,675 |
| JardianceEmpagliflozin | 23 | $16,448 |
| LinzessLinaclotide | 25 | $12,693 |
| TradjentaLinagliptin | 18 | $10,752 |
| JanuviaSitagliptin Phosphate | 12 | $8,787 |
| KerendiaFinerenone | 14 | $8,364 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,154 |
| Atorvastatin Calcium | 79 | $1,111 |
| Tamsulosin Hcl | 41 | $969 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $768 |
| Lisinopril | 81 | $703 |
| Gabapentin | 73 | $618 |
| Ibuprofen | 67 | $579 |
| Pantoprazole Sodium | 40 | $489 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $647 | $30,17135 claims |
| AstraZenecaFarxiga | $319 | $27,67542 claims |
| Boehringer IngelheimJardiance, Tradjenta | $404 | $27,20041 claims |
| AbbVieLinzess | $254 | $12,69325 claims |
| MerckJanuvia | $66 | $8,78712 claims |
| BayerKerendia | $269 | $8,36414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Bakersfield
- Jennifer TougasBakersfield$302K
- Ashton ChaseBakersfield$86K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.